Literature DB >> 7850197

Balancing the drug-resistance equation.

S B Levy1.   

Abstract

Mesh：

Year:  1994        PMID： 7850197     DOI： 10.1016/0966-842x(94)90607-6

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  22 in total

1.  Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans.

Authors:  L E Cowen; L M Kohn; J B Anderson
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  Role of Antimicrobial Stewardship in Prevention and Control of Antibiotic Resistance.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 3.  Antimicrobial resistance--pharmacological solutions.

Authors:  E Rubinstein
Journal:  Infection       Date:  1999       Impact factor: 3.553

4.  Combining mathematical models and statistical methods to understand and predict the dynamics of antibiotic-sensitive mutants in a population of resistant bacteria during experimental evolution.

Authors:  Leen De Gelder; José M Ponciano; Zaid Abdo; Paul Joyce; Larry J Forney; Eva M Top
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

Review 5.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 6.  Production of recombinant antibodies using bacteriophages.

Authors:  A M Shukra; N V Sridevi
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-05-21

7.  Diagnosing bacterial infectious diseases in one hour: an essential upcoming revolution.

Authors:  M G Bergeron; M Quellette
Journal:  Infection       Date:  1995 Mar-Apr       Impact factor: 3.553

Review 8.  Selective pressure by antibiotics as feed additives.

Authors:  W Witte; I Klare; G Werner
Journal:  Infection       Date:  1999       Impact factor: 3.553

9.  Adaptation to the fitness costs of antibiotic resistance in Escherichia coli.

Authors:  S J Schrag; V Perrot; B R Levin
Journal:  Proc Biol Sci       Date:  1997-09-22       Impact factor: 5.349

10.  AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis.

Authors:  Melissa A Visalli; Ellen Murphy; Steven J Projan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.